PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
March 18, 2009Annals of Pharmacotherapy

Neuroleptic Malignant Syndrome Secondary to Quetiapine

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does quetiapine cause neuroleptic malignant syndrome with extrapyramidal symptoms?

Population

34-year-old male with a history of severe brain damage, mental retardation, and seizures

Design

Case_report

Follow-up

7 days

Key result

A 34-year-old male developed neuroleptic malignant syndrome with extrapyramidal symptoms after receiving quetiapine 200 mg three times daily for at least a month without recent dosage adjustments.

Authors

JGJustine S. GortneyAFAlexandria FaganJKJulie C. Kissack

Discussion

Loading...

Member takes

Overview

Quetiapine may trigger NMS with EPS at stable doses; single case leaves open causality and generalizability.

Study Design

Type

Case Report (n=1)

Structured PICO

Does quetiapine cause neuroleptic malignant syndrome with extrapyramidal symptoms?

P
Population
A 34-year-old male with severe brain damage, mental retardation, and seizures who developed neuroleptic malignant syndrome secondary to quetiapine.
E
Exposure
Quetiapine 200 mg 3 times per day (along with guanfacine, carbamazepine, valproic acid, and lorazepam)
O
Outcome
Development of neuroleptic malignant syndrome (NMS) with extrapyramidal symptoms (EPS)safety

Clinicians should be aware that neuroleptic malignant syndrome with extrapyramidal symptoms can occur with quetiapine at steady state doses without recent dosage adjustments.

Cite This Study

Gortney et al. (2009) conducted a case report in Neuroleptic malignant syndrome (n=1). Quetiapine was evaluated on Development of neuroleptic malignant syndrome with extrapyramidal symptoms. A 34-year-old male developed neuroleptic malignant syndrome with extrapyramidal symptoms after receiving quetiapine 200 mg three times daily for at least a month without recent dosage adjustments.

synapsesocial.com/papers/6a9cd29f05f4788b74b6871bhttps://doi.org/10.1345/aph.1l371
View Full Paper
Ask AI
Bookmark
Share